The pharmaceutical labelling market will likely register robust growth in the near future, as e-pharmacy, and growing demand to cater to chronic illnesses drives growth. World Health Organizations estimates that NCDs or Non-Communicable Diseases remain leading cause of death worldwide, as over it kills over 41 million people each year. Moreover, this translates to over 71% of total recorded deaths globally. The NCDs like heart disease, diabetes, strokes are also starting to plague among younger population, due to growth of sedentary lifestyle, limited access to medical treatments, and low adherence to medicines. The e-pharmacy market promises to solve two major issues including limited access to treatment for rural folks who suffer proportionately more due to NCDs in major countries like the US. Moreover, WHO also notes that treatment outcomes can be significantly better with strict adherence to medical schedules. NCDs often require long-term care, which is becoming a rare treat for patients as nuclear households, and demand for a mobile workforce make patients more vulnerable. However, e-pharmacy promises to couple essential feature like digital alerts, along with medication to improve treatment outcomes. The demand for chronic illnesses, and stringent legislations guiding labelling, and rising demand for RFID tags to monitor health data will be a major boost for growth for the pharmaceutical labelling market.
Read More@https://www.insightslice.com/pharmaceutical-labelling-market
